StockMarketWire.com - Investor Group Braveheart acquired a 33% stake in Pharm2Farm, a spin out from Nottingham Trent University.
Nottingham Trent University (NTU) and Pharm2Farm (P2F) had developed and patented a process to increase the bioavailability of trace minerals in plant feeds.
Their patented process uses nanotechnology to dramatically improve trace element take-up in both flower and crop farming. P2F produces and sell these products through an exclusive licence to this technology from NTU.
'The Board of Braveheart believes there is a substantial market opportunity for this technology and is in negotiations to take the Group's shareholding in P2F to 54% by way of a working capital investment,' the commpany said.
At 8:31am: [LON:BRH] Braveheart Investment Group PLC share price was +0.75p at 10.5p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.